Selegiline Hydrochloride

CAS 14611-52-0 12 FDA-DMF suppliersSmall Molecule

Overview

Selegiline Hydrochloride is a selective monoamine oxidase B (MAO-B) inhibitor primarily used in the treatment of Parkinson's disease. It may also be used in the treatment of major depressive disorder.

API suppliers (12)

Suppliers of Selegiline Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • EUROAPI HUNGARY LTDHungary1 active DMF
  • Dipharma Francis SrlItaly1 active DMF
  • EUROAPI HUNGARY LTDHungary1 active DMF
  • Dipharma Francis SrlItaly1 active DMF
  • EUROAPI HUNGARY LTDHungary1 active DMF
  • WYCKOFF CHEMICAL CO INC
  • ALCHYMARS SPA
  • Taro Pharmaceutical Industries Ltd.Israel
  • SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany
  • IROTEC LABORATORIES
  • SIEGFRIED USA LLC
  • RESOLUTION CHEMICALS LTD

Therapeutic areas

NeurologyPsychiatry

Related APIs

Aripiprazole
45 suppliers
Pregabalin
40 suppliers
Lurasidone Hydrochloride
35 suppliers
Lamotrigine
33 suppliers
Quetiapine Fumarate
29 suppliers
Risperidone
27 suppliers
Escitalopram Oxalate
27 suppliers
Olanzapine
27 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo